Skip to content

Clinical trials

Phase 3 Immunologic Deficiency Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunologic Deficiency Syndromes Phase: Phase 3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20061
20071
20092
20111
20141
20161
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Green Cross Corporation2
National Institute of Allergy and Infectious Diseases (NIAID)2
ADMA Biologics, Inc.1
Baxalta now part of Shire1
FFF Enterprises1
Grifols Therapeutics LLC1
Octapharma1
On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.1
Radboud University Medical Center1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunologic Deficiency Syndromes13
Primary Immunodeficiency Diseases4
Acquired Immunodeficiency Syndrome2
Agammaglobulinemia2
Common Variable Immunodeficiency2
HIV Infections2
Infections2
Aspergillosis1
Cachexia1
Hyper-IgM Immunodeficiency Syndrome1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.